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Abstract
Background: Neuroblastoma (NB) is an extra-cranial solid tumour of childhood. In spite of the
good clinical response to first-line therapy, complete eradication of NB cells is rarely achieved.
Thus, new therapeutic strategies are needed to eradicate surviving NB cells and prevent relapse.
Sodium ascorbate has been recently reported to induce apoptosis of B16 melanoma cells through
down-regulation of the transferrin receptor, CD71. Since NB and melanoma share the same
embryologic neuroectodermal origin, we used different human NB cell lines to assess whether the
same findings occurred.
Results: We could observe dose- and time-dependent induction of apoptosis in all NB cell lines.
Sodium ascorbate decreased the expression of CD71 and caused cell death within 24 h. An
increase in the global and specific caspase activity took place, as well as an early loss of the
mitochondrial transmembrane potential. Moreover, intracellular iron was significantly decreased
after exposure to sodium ascorbate. Apoptotic markers were reverted when the cells were
pretreated with the iron donor ferric ammonium citrate (FAC), further confirming that iron
depletion is responsible for the ascorbate-induced cell death in NB cells.
Conclusion:  Sodium ascorbate is highly toxic to neuroblastoma cell lines and the specific
mechanism of vitamin C-induced apoptosis is due to a perturbation of intracellular iron levels
ensuing TfR-downregulation.
Background
Neuroblastoma is the most common solid extracranial
tumor of childhood [1]. This tumor has long fascinated
clinicians and biologists due to its enigmatic behaviour.
Extreme clinical heterogeneity is seen, including sponta-
neous regression. Still, a large part of neuroblastoma
patients have highly aggressive disease that is refractory to
intensive therapies and ultimately fatal. Current therapy
for high risk neuroblastoma has reached a near-maximally
tolerable state that includes cytoreductive and myeloabla-
tive therapies, radiation, autologous or allogenic bone
marrow transplant, retinoids and immunomodulators,
among others [2].
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Therefore, less toxic and more effective therapy are to be
found.
It has been recently reported that vitamin C is effective in
a large panel of tumor cell lines [3,4]. Sodium Ascorbate
(vitamin C) has a controversial history in cancer treat-
ment. The discrepancy obtained in research and analysis
by many authors was principally due to the different dose
and route of administration of vitamin C and conse-
quently to its plasma concentration [5-7].
Given this situation, the role of vitamin C in cancer treat-
ment has been reexamined; in fact apparent responses of
malignant disease to intravenous ascorbate therapy have
appeared as case reports [5,6,8]. Some in vitro studies
showed that ascorbate causes toxicity to cancer cells at
concentration that do not affect normal cells [3,9,10]; fur-
thermore, it was reported that melanoma cells were more
susceptible to ascorbate toxicity than any other tumor
cells. Ascorbate seems to induce apoptosis by inducing
disequilibrium of iron uptake due to down-regulation of
transferrin receptor [4]. Since melanoma and neuroblast-
oma have the same embryological neuroectodermal ori-
gin, we investigated whether neuroblastoma cell lines
have the same susceptibility to vitamin C. First we studied
the expression of transferrin receptor in neuroblastoma
cell lines. Neoplastic cells were reported to express high
rate of transferrin receptor, because growing cells have an
increased requirement of iron [11]. Neuroblastoma cells
are not an exception to this general rule, to the point that
iron chelators have been proposed for the treatment of
this kind of tumor [12,13].
Results
Effect of Sodium Ascorbate on neuroblastoma cell lines
We first investigated whether sodium ascorbate had cyto-
toxic effects on neuroblastoma cell lines. Therefore we
used sodium ascorbate at millimolar concentration rang-
ing from 0.5 mM to 3 mM for 24 hours. Vitamin C con-
centrations causing a 50% decrease in cell survival after 24
hours (EC50 values, table 1) were less than 2 mM for all
five cell lines, as assessed by trypan blue exclusion
method. Morphological inspection of treated cells, sug-
gested that cell death took place through apoptosis rather
than necrosis. This was confirmed by cytofluorimetric
analysis of DNA content. There was a dose- and time-
dependent increase of cells in the sub-G1 phase of the cell
cycle (typical of apoptotic cells) upon treatment with
sodium ascorbate (fig. 1).
Sodium ascorbate induced-down regulation of TfR 
expression
Many tumor cells display high level of transferrin receptor
to meet the increase in iron supply required by growing
cells [11] and several authors have reported that antibod-
ies against TfR have antiproliferative effects in vitro and in
vivo [14,15]; furthermore, it was reported that in
melanoma cells ascorbate induced down-regulation of
cell surface TfR [4]. In the present work, all the neuroblas-
toma cells analyzed expressed TfR (fig. 2). Addiction of
sodium ascorbate resulted in a concentration dependent
down-regulation of TfR; besides, TfR change of expression
seemed to be time independent, since there was a substan-
tial decrease of CD71 expression at 6 hours and did not
significantly decrease at 24 hours (fig. 2).
Intracellular iron level
In order to find the possible mechanism of neuroblast-
oma cells apoptosis induced by vitamin C, we investigated
whether this phenomenon was correlated with change in
the intracellular iron levels; therefore we treated HTLA-
230 and SH-SY5Y for 24 hours with 1.5, and 2 mM
sodium ascorbate and iron level was then measured. As
shown in fig. 3 vitamin C significantly reduced intracellu-
lar iron levels in a dose-dependent manner.
Effect of vitamin C on mitochondrial membrane potential
It is well established that the reduction of ∆ψm also plays
a key role in triggering apoptosis [16]. Treatment with
vitamin C induced depolarization of the mitochondrial
transmembrane potential in all neuroblastoma cell lines
investigated (fig. 4, panel A2, A4, panel B2, B4).
To confirm that iron is involved in the induction of apop-
tosis we tested whether the iron donor ferric ammonium
citrate (FAC) was able to prevent the sodium ascorbate-
induced apoptosis. To this aim before incubation with 2
mM of vitamin C, we treated HTLA-230 cells with 70 µg/
ml of FAC for 3 hours; afterwards we assessed the induc-
tion of apoptosis by phosphatidylserine externalization
using FITC-Annexin V binding.
The data depicted in fig. 5 show that the peak of apoptosis
induced by ascorbate is nearly abolished by the pretreat-
ment with the donor of iron FAC; in fact the percentage of
Annexin V-positive cells decreased from 82% (cells incu-
bated only with ascorbate) to 15% (cells incubated with
ascorbate and pretreated with FAC). Similar results were
obtained when we analyzed changes in the mitochondrial
membrane potential (∆ψm) in HTLA- 230 and SH-SY-5Y,
measured as the ratio of red-to-green JC-1 fluorescence
(fig. 4). Treatment with vitamin C induced depolarization
of the mitochondrial transmembrane potential in all neu-
roblastoma cell lines investigated and the effect was inhib-
ited by FAC.
Sodium Ascorbate-induced apoptosis is mediated by 
caspases activation
Apoptosis arises from proteolytic activation of the
cysteine proteases called caspases [17,18]. To verify theMolecular Cancer 2007, 6:55 http://www.molecular-cancer.com/content/6/1/55
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involvement of caspases in sodium ascorbate-induced
apoptosis in neuroblastoma cell lines, we used a fluores-
cence-based pan-caspase activity assay kit. Cells were
treated with increasing concentrations of sodium ascor-
bate for 12 and 24 hours before incubation with the fluo-
rescent probe. The results showed a dose-dependent shift
in fluorescence in all tested cell lines, revealing a signifi-
cant participation of caspases in ascorbate-induced apop-
tosis (in fig. 6 are represented only SH-SY5Y and HTLA-
230, similar data were obtained for GI-LI-N, IMR-32 and
LAN-5, data not shown). Moreover the activation of cas-
pases was an early event; in fact there was not significant
difference in fluorescence increase between 12 and 24
hours of incubation. To understand which caspases was
mainly involved in the apoptotic mechanism, we used all
the commercially available kits for single caspases (i.e.,
caspase-1, caspase-2, caspase-3&7, caspase-6, caspase-8,
caspase-9, and caspase-10) and measured the increase in
fluorescence after 16 hours in SH-SY5Y and HTLA-230 cell
lines. As depicted in fig. 7, all the above caspases showed
a similar pattern of activation, in particular in SH-SY5Y
caspases were already activated at 1 mM ascorbate.
Although these experiments did not allow us to individu-
ate a hierarchy of activation, they clearly confirmed the
apoptotic nature of cell death induced by sodium ascor-
bate in neuroblastoma cell lines.
Discussion
The effect of vitamin C on cancer has been a subject of
great controversy, and vast literature exists on this topic.
Thirty years ago Cameron, Campbell and Pauling
reported that high-dose vitamin C had beneficial effect for
patient with terminal cancer. Subsequently, double-blind,
randomized clinical trials, conducted by Moertel of the
Mayo clinic, failed to show any benefit and the use of
sodium ascorbate in cancer treatment was abandoned
[19-24]. However, Moertel's results were not comparable
Table 1: EC50 values of vitamin C in human neuroblastoma cell 
lines. Cells were treated with sodium ascorbate for 24 h, EC50 
values were determined by using trypan blue exclusion method. 
Values indicated are the mean ± S.D. of three separate 
experiments.
Neuroblastoma cell lines EC50 (mM) 24 h
HTLA-230 1.78 ± 0.3
IMR-32 0.89 ± 0.04
LAN-5 0.88 ± 0.03
GI-LI-N 0.98 ± 0.04
SH-SY5Y 1.44 ± 0.2
Sodium ascorbate induces apoptosis in neuroblastoma cell lines Figure 1
Sodium ascorbate induces apoptosis in neuroblastoma cell lines. Cells were seeded in six well plates and treated for 6 or 24 
hours with increasing concentrations of sodium ascorbate. For each bar group, the concentration was: 0 mM (control), 0.5 
mM, 1 mM, 2 mM, 3 mM. Cells were then processed and stained with propidium iodide as described in "Materials and Meth-
ods". The percent of cells in the sub-G1 phase of the cell cycle were considered apoptotic. The data are the mean ± S.D. from 
three independent experiments.
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to those of Cameron, as ascorbate was given orally and
not intravenously. It was not recognized that the route of
administration might produce large difference in plasma
concentration. Recent clinical data show that when given
i.v., ascorbate plasma concentration is 25 fold higher
respect that of the same oral dose [7].
Sodium ascorbate produces cytotoxic effect in an array of
malignant cell lines, including melanoma cells which are
particularly susceptible [3,4,9,10].
In light of these results we investigated the effect of
sodium ascorbate against neuroblastoma.
Our data show that sodium ascorbate killed neuroblast-
oma cells, using lower concentrations compared to those
active in other tumor cell lines; in fact vitamin C, in the
range of 0.5 to 3 mM turned out to be strongly cytotoxic.
To broadly cover the phenotype of the tumor we used five
neuroblastoma cell line including MYCN amplified
(HTLA-230 and IMR-32) and not-MYCN amplified (SH-
SY5Y). Sodium ascorbate-induced cell death was apopto-
sis, as documented by our experiments regarding the
decrease of mitochondrial membrane potential, the phos-
phatidylserine externalization, the increase of cells in the
sub-G1 phase of the cell cycle and caspases activation.
Membrane expression of TfR (CD71) by neuroblastoma cell lines and its modulation by sodium ascorbate Figure 2
Membrane expression of TfR (CD71) by neuroblastoma cell lines and its modulation by sodium ascorbate. Cells were seeded 
in six well plates and treated for 6 and 24 hours with increasing concentrations of sodium ascorbate. For each bar group, the 
concentration was: 0 (control), 0.5 mM, 1 mM, 2 mM and 3 mM. Cells were than washed and incubated with a FITC-coniugated 
mouse monoclonal antibody specific to human CD71 and analyzed by flow cytometry. The data are the mean ± S.D. from 
three independent experiments, each in triplicate.
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Reduction of intracellular iron levels by sodium ascorbate Figure 3
Reduction of intracellular iron levels by sodium 
ascorbate. 30 × 106 of either HTLA-230 or SH-SY5Y were 
treated with the indicated doses of sodium ascorbate for 24 
hours and iron levels were measured in cell lysates. After 
terminating the incubation, cells were collected by scraping 
and washed three times with PBS and then lysed in specific 
buffer. Iron levels were analyzed with a Cobas Integra 800 
system as described under "Material and Method". Values 
indicated are the mean ± S.D. of three separate experiments.
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In this study we show that all the caspases are activated by
the incubation with vitamin C, in fact, not only caspases
related to the mitochondrial pathway were found to be
activated but also those related to the death receptor path-
way. The two pathways, extrinsic and intrinsic, are proba-
bly interconnected by caspase-8 mediated cleavage of the
pro-apoptotic Bcl-2 family member Bid, producing a trun-
cated Bid (tBid) fragment that promotes the mitochon-
drial release of proteins from the intermembrane space. In
particular, it is known, that the release of cytochrome c
induces the activation of caspase proteases through the
induction of apoptosome formation [25].
To clarify if ascorbate-mediated cytotoxicity was due to
perturbation in the iron uptake, we measured intracellular
iron level of HTLA-230 and SH-SY5Y after 24 hours of
incubation with increasing doses of vitamin C. We could
observe a dose-dependent decrease of iron levels; further-
more, pretreatment of cells with the iron donor FAC com-
pletely prevented sodium ascorbate-induced apoptosis.
Thus, the percentage of Annexin V positive cells decreased
to that of untreated cells and, in a similar way, the pre-
treatment with FAC completely abolished the ascorbate-
induced reduction of mitochondrial membrane potential.
Several studies report the correlation of iron level with
apoptosis [26,27]. Virtually all living cells have an abso-
Representative example of cytofluorimetric analysis showing the effect of vitamin C alone or in combination with FAC, on the  mitochondrial membrane potential of SH-SY5Y (panel A) and HTLA-230 (panel B) stained with JC-1 probe Figure 4
Representative example of cytofluorimetric analysis showing the effect of vitamin C alone or in combination with FAC, on the 
mitochondrial membrane potential of SH-SY5Y (panel A) and HTLA-230 (panel B) stained with JC-1 probe. In abscissa FL-1 
(green fluorescence); in ordinate FL-2 (red fluorescence). Numbers represent the percentage of non-apoptotic red fluorescent 
cells (R1, R3) and that of apoptotic green fluorescent cells (R2, R4). Sodium ascorbate induces a marked increase in apoptosis 
which is fully prevented by treatment with FAC. SH-SY5Y and HTLA-230 were incubate in complete medium in the absence 
(A1, B1) or in presence of 1 mM sodium ascorbate (A2, B2) and 2 mM sodium ascorbate (A4, B4) for 16 hours. Cells were pre-
treated (A3, A5, B3, B5) with 70 µg/ml of FAC for 3 hours. Comparable results were obtained in three independent experi-
ments.
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lute requirement for iron, since many Fe-containing pro-
teins catalyze key reactions involved in energy
metabolism (cytochromes, mitochondrial aconitase, Fe-S
proteins of the electron transport chain), respiration
(hemoglobin), and DNA synthesis (ribonucleotide
reductase) [11]. Inhibition of ribonucleotide reductase
has been proposed as the cause of the growth arrest that
occurs in cell deprived of iron because this enzyme
requires iron to reduce ribonucleotides to form the sub-
strate of DNA synthesis [28-30]. The regulated uptake and
availability of iron is closely linked to cellular prolifera-
tion. Three proteins, the iron-transport transferrin, the
transferrin receptor on the cell surface and ferritin are
essential for making iron available for cellular use. Many
neuroblastomas produce very large amount of ferritin
[12]. In addition to being incorporated into heme pro-
teins and enzymes, iron may participate more directly in
the regulation of cell growth and apoptosis of neuroblas-
toma; in fact neuroblastoma cells appear to be unusually
sensitive to the cytotoxic and cytostatic effect of iron che-
lators [31]. Furthermore the mechanism by which vitamin
C decreased intracellular iron level seems to be correlated
with the down-regulation of transferrin receptor. Our data
are consistent with the fact that tumor cells express high
level of transferrin receptor to meet the increase in iron
required by growing tumor tissue [11].
Some in vitro studies showed that ascorbate causes toxicity
to cancer cells at concentrations that do not affect normal
cells [3,9]; this phenomenon is probably due to a tumor
specific intracellular transport of ascorbate. Extracellular
ascorbate is oxidized, transported as dehydroascorbic
acid, and reduced intracellularly to ascorbate [32]. Many
cell types transport ascorbate only in its oxidized form,
through facilitated glucose transporters [33]. Tumor cells
have an increased requirement for glucose [34] and to
compensate for this they increase the expression of glu-
cose transporters. This allows ascorbate to act as a selec-
tive, non toxic to normal cells, chemotherapeutic.
Conclusion
This study demonstrates that sodium ascorbate is highly
toxic to neuroblastoma cell lines and the specific mecha-
nism of vitamin C -induced apoptosis is due to a pertur-
bation of intracellular iron levels ensuing TfR-
downregulation.
Effect of FAC on sodium ascorbate-induced apoptosis Figure 5
Effect of FAC on sodium ascorbate-induced apoptosis. HTLA-230 were grown in either complete medium alone (con-
trol cells), or medium containing 2 mM of sodium ascorbate (in the presence or absence of FAC 70 µg/ml). After 16 hours, 
cells detached in the medium were collected by centrifugation, resuspended and incubated with AnnexinV-FITC. Apoptosis 
was quantified as increased green fluorescence by flow cytometry. The data are the mean ± S.D. from four independent exper-
iments. Statistical analysis was done by Student's test (*, p < 0.005).
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This work, together with others, supports the use of vita-
min C as an anticancer agent; in particular we suggest
exploring the use of high dose intravenous ascorbate in
controlled studies. Besides, vitamin C is relatively tumor
specific, non toxic and inexpensive, in contrast to many
chemotherapeutic agents in use.
Methods
Reagents
Sodium ascorbate and ferric ammonium citrate (FAC)
were purchased from Sigma (St. Louis, MO). Ascorbate
was dissolved in PBS, pH 7.4, and prepared immediately
before use.
Monoclonal antibody to transferrin receptor (TfR, CD71)
was obtained from BD biosciences (San Jose, CA).
Cells
To broadly cover the phenotypes exhibited by NB cell in
vitro, we used five human NB cell lines: SH-SY5Y [35],
HTLA-230 [36], LAN-5 [37], IMR32 [38] and GI-LI-N
[39]. All cell lines were grown in Dulbecco's modified
Eagle medium supplemented with 10% fetal bovine
serum (GIBCO Milan Italy) and 50 UI/ml penicillin, 50
µg/ml streptomycin and 2 mM L-glutamine (all reagent
from Sigma). Cells were cultured at 37°C in a humidified
atmosphere of 5% CO2 in air. Most experiments were per-
formed on SH-SY5Y and HTLA-230, unless otherwise
specified.
Trypan blue exclusion method
The effects of sodium ascorbate on cell death were deter-
mined by trypan blue exclusion method as described else-
where. Briefly, cells were seeded in 6-well plates, and, after
48 h, treated in absence or presence with various concen-
trations of vitamin C for 24 hours. Then, cells were
trypsinized and diluted in growth medium. The cells were
then counted under a phase-contrast microscopy, in a
Burker counting chamber, in the presence of trypan blue
(Sigma) solution at a 1:5 ratio, cells: trypan, (v/v).
Cell cycle analysis
HTLA-230, IMR-32, LAN-5 and GI-LI-N were seeded in six
well plates and treated in the absence or presence of
increasing concentration of sodium ascorbate (0.5 mM, 1
mM, 2 mM and 3 mM) for 6 or 24 hours. Cells were har-
vested and washed with cold PBS, centrifuged at 1200
rpm and stored overnight in ethanol at -20°C. The follow-
ing day, cells were washed with cold PBS, resuspended in
0.1% NP40, 100 µg/ml RNase A, 35 µg/ml propidium
iodide (PI) and incubated for 20 minutes at 37°C. The
stained cells were analyzed for DNA content by flow
Effect of vitamin C on caspases activation Figure 6
Effect of vitamin C on caspases activation. HTLA-230 and SH-SY5Y were treated with the indicated concentrations for 12 and 
24 hours. After detachment, cells were stained with the pan-caspase-fluorescent-probe z-VAD-FMK according to the manufac-
tures instructions. Relative increases in fluorescence emission were detected by single color flow cytometry. The data are the 
mean ± S.D. from three independent experiments.
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Effect of sodium ascorbate on single caspases activation Figure 7
Effect of sodium ascorbate on single caspases activation. HTLA-230 and SH-SY5Y were incubated in the absence (0 mM) or 
presence of the indicated concentrations for 16 hours and then analyzed for single caspases by flow cytometry as described in 
Material and Method. Coloums, mean of three different experiments, each done in triplicate; bars, SD.
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cytometry in a FACScan (Becton Dickinson, San Jose, CA)
equipped with a 15-mW argon ion laser at 448 nm.
Measurement of intracellular iron levels
HTLA-230 cells (30 × 106) were cultured for 24 hours in
presence or absence of 1.5 or 2 mM sodium ascorbate.
Cells were then washed with PBS and homogenized in
lysis buffer (10 mmol/L Tris-HCl, 144 mmol/L NaCl,
0.5% NP-40, 0.5% SDS, 1 mmol/L Na3VO4 plus protease
inhibitors). Iron concentration in cell lysates was per-
formed with a Cobas Integra 800 system (Roche Diagnos-
tics GmbH, Mannheim, Germany) as routinarily assessed
on plasma or serum samples by an Iron Test (Roche Diag-
nostics); iron concentration was estimated by absorbance
at 552 nm.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential was detected with the
MitoPT™ Mitochondrial Permeability Transition Kit
(Alexis).
Loss of the mitochondrial permeability transient event
(PT) provides an early indication of the initiation of cellu-
lar apoptosis. This process is typically defined as a collapse
in the electrochemical gradient across the mitochondrial
membrane, as measured by the change in the membrane
potential (∆Ψm). Loss of the mitochondrial ∆Ψ, can be
detected by a unique fluorescent cationic dye, 5, 5', 6, 6'-
tetrachloro-1, 1', 3, 3'-tetraethyl-benzamidazolocarbocy-
anin iodide, commonly known as JC-1, incorporated into
the MitoPT™ kit. The dye penetrates cells and healthy
mitochondria. Once inside a healthy non-apoptotic cell,
the reagent bearing a positive charge, enters the negatively
charged mitochondria were it aggregates and fluoresces
red. When the mitochondrial ∆Ψ collapses in apoptotic
cells, the reagent no longer accumulates inside the mito-
chondria. Instead, it is distributed throughout the cell.
When dispersed in this manner, the MitoPT™ reagent
assumes a monomeric form, which fluoresces green.
Then, it is easily distinguishable between non-apoptotic
red fluorescent and apoptotic green fluorescent cells
[40,41].
HTLA-230 and SH-SY5Y cells (1 × 106 cell/ml) were pre-
treated, or not, for 3 hours with 70 µg/ml FAC and then
treated with sodium ascorbate for 18 hours. Cells were
washed and resuspended in 0.5 ml of 1× MitoPT and incu-
bated at 37°C for 15 minutes. After incubation, cells
underwent to multi-parameter analysis using a flow
cytometer.
Annexin assay
Apoptotic cells were detected by Annexin V staining using
the Annexin V-FITC kit purchased from Pharmingen (San
Diego, CA) following the instructions of the manufac-
turer.
Briefly, HTLA-230 treated with sodium ascorbate and with
or without FAC were washed with cold PBS and then
resuspended in 1× binding buffer at a concentration of 5
× 105 cell/ml.
195 µl of cell suspension was transferred to a tube, then 5
µl of Annexin V-FITC was added and cells were incubated
at room temperature for 10 minutes in the dark with gen-
tle vortexing. Cells were then washed and resuspended in
200 µl of 1× binding buffer and analyzed by flow citome-
try.
Caspase activity assay
The FLICA Apoptosis Detection Kit (Alexis, San Diego,
CA) was used to detect ascorbate-induced activation of
caspases in neuroblastoma cells, according to the manu-
facturer instructions, by flow cytometry. The FAM-VAD-
FMK reagent provided in the kit is a carboxyfluorescein
(FAM) derivative of benzyloxycarbonyl valyl alanyl aspar-
tic acid fluoromethyl ketone (zVAD-FMK), which is a
potent inhibitor of caspase activity. It enters the cell and
irreversibly binds to activated caspases (caspases 1, 2, 3, 4,
5, 6, 7, 8, and 9) allowing for direct detection of pan-cas-
pases activity by green fluorescence in live cells [42].
Briefly, cells were detached by trypsinization and centri-
fuged at 400 × g for 5 minutes at room temperature. Cell
supernatants were removed and the pellets resuspended
in a buffer containing the pan-caspase-fluorescent probe.
After 1 hour of incubation, samples were washed and ana-
lyzed by single color flow cytometry at 488 nm for fluores-
cein on the FL1 channel.
To assess which caspase was mainly involved in ascorbate-
induced apoptosis, we used all the commercially available
kits specific for single caspases, i.e., FAM-YVAD-FMK for
caspase-1, FAM-VDVAD-FMK for caspase-2, FAM-DEVD-
FMK for caspases-3&7, FAM-VEID-FMK for caspase 6,
FAM-LETD-FMK for caspase 8, FAM-LEHD-FMK for cas-
pase 9 and FAM-AEVD-FMK for caspase-10. All kits were
obtained from Alexis (San Diego, CA).
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